Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Docs Still Like Sales Reps To Deliver Samples
Pharmalot
Wednesday, July 28, 2010 - 10:36am
tags:
drug reps, physicians, samples
Sun Pharmaceutical 1Q Net Profit Soars To INR5.64 Bln; Tops View
WSJ Online
Wednesday, July 28, 2010 - 10:31am
tags:
Sun Pharma, earnings
Can Trius get market mojo working with $84M IPO?
Fierce Biotech
Wednesday, July 28, 2010 - 10:29am
tags:
Trius Therapeutics, IPOs
Regeneron inks $295M antibody discovery deal with Astellas
Fierce Biotech
Wednesday, July 28, 2010 - 10:26am
tags:
antibody discovery, Regeneron, Astellas
Merck KGaA's Cladribine Multiple Sclerosis Pill Gets Faster Review in U.S.
Bloomberg
Wednesday, July 28, 2010 - 10:22am
tags:
Merck KGaA, multiple sclerosis, MS, cladribine, Novartis, Gilenia
AstraZeneca bloodthinner Brilinta goes before U.S. experts
Reuters
Wednesday, July 28, 2010 - 10:19am
tags:
Brilinta, blood thinners, AstraZeneca, FDA, advisory panels
Big Biotech: End of an Era
Seeking Alpha
Wednesday, July 28, 2010 - 10:17am
tags:
Alexion, Amgen, Amylin, Biogen Idec, Biomarin, Celgene, Genentech, Dendreon, Genzyme, Gilead Sciences, GSK, Roche, Human Genome Sciences, Vertex Pharmaceuticals, Sanofi
Transdel Pharma Stands to Gain From Pain Medication
Seeking Alpha
Wednesday, July 28, 2010 - 10:14am
tags:
Transdel, Ketotransdel
Antigenics: Bright Future Ahead
Seeking Alpha
Wednesday, July 28, 2010 - 10:13am
tags:
Antigenics
United Therapeutics back in black as revenue jumps 64%
Bizjournals.com
Wednesday, July 28, 2010 - 10:09am
tags:
United Therapeutics, earnings
Earnings Scorecard: Forest Labs
Yahoo/Zacks.com
Wednesday, July 28, 2010 - 10:08am
tags:
Forest Labs, earnings
Genzyme Giving Sanofi-Aventis the Cold Shoulder?
Seeking Alpha
Wednesday, July 28, 2010 - 10:06am
tags:
Genzyme, Sanofi, M&A, GSK, JNJ
Is Johnson & Johnson Really a Safety Stock?
Seeking Alpha
Wednesday, July 28, 2010 - 10:00am
tags:
JNJ, GSK, Novartis, Sanofi, AstraZeneca
Merck declares 38-cent regular quarter dividend
Yahoo/AP
Wednesday, July 28, 2010 - 9:56am
tags:
Merck, dividends
Merck Paid 3,468 Death Claims to Resolve Vioxx Suits
Bloomberg
Wednesday, July 28, 2010 - 12:53am
tags:
Merck, settlements, Vioxx
Dynavax starts universal flu vaccine test
Bizjournals.com
Wednesday, July 28, 2010 - 12:50am
tags:
Dynavax, Flu, vaccines
Better Buy: Cell Therapeutics or Sequenom?
Motley Fool
Wednesday, July 28, 2010 - 12:48am
tags:
Sequenom, Cell Therapeutics
Drug Company as Masochist: Bristol-Myers Takes Needless Whipping for HIV Drug Prices
BNET Pharma
Wednesday, July 28, 2010 - 12:45am
tags:
HIV, drug pricing, Bristol-Myers Squibb
Antigenics posts positive herpes drug study data
Yahoo/AP
Tuesday, July 27, 2010 - 8:39pm
tags:
Antigenics, genital herpes, herpes simplex 2
Cephalon second-quarter profit rises to $89 mln
Marketwatch
Tuesday, July 27, 2010 - 8:37pm
tags:
Cephalon, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.